Abstract navy blue geometric composition of layered circles and rectangles over a horizontal grid, suggesting a protective boundary drawn around a transaction
M&A Advisory

Representations and Warranties Insurance: A Softer Market Reaches Smaller Deals

As premiums compress and coverage extends into the lower middle market, more sellers can shift deal risk to an insurer and keep more of their proceeds at closing.
KAS Advisors • July 27, 2026 7 min read

When a company changes hands, the seller stands behind dozens of promises about the business, and for years those promises were secured by a chunk of the purchase price left sitting in escrow. Representations and warranties insurance moves that risk to a third-party insurer, and in 2026 the coverage has become cheaper and available on smaller transactions than it was even two years ago. For business owners weighing a sale, that shift changes how much cash arrives at closing and how much exposure follows them afterward.

What the Policy Actually Covers

In any acquisition, the purchase agreement contains a long list of representations and warranties: statements the seller makes about the company. The financial statements are accurate, taxes have been filed and paid, no undisclosed litigation is pending, customer contracts are valid, the company owns its intellectual property, and so on down the list. These promises give the buyer a basis to recover money if something turns out to be untrue after closing.

Traditionally, that recovery ran straight back to the seller through indemnification, a contractual obligation to reimburse the buyer for covered losses. To make sure the money would be there, buyers held back part of the price in escrow, commonly 10 percent or more, for a year or two after closing. If a representation proved false, the buyer drew on the escrow. If the escrow ran short, the buyer could pursue the seller directly.

Representations and warranties insurance, usually purchased by the buyer, replaces most of that machinery. The policy covers losses from breaches of the seller's representations, so the buyer collects from an insurer rather than from the seller's escrow. The coverage limit typically matches the representations and warranties cap negotiated in the purchase agreement, and the seller's post-closing exposure shrinks to a small retention or, in some deals, to close to nothing.

The policy lets a buyer collect from an insurer rather than chase the seller, which is precisely why sellers tend to like it as much as buyers do.

Why the 2026 Market Favors Dealmakers

Pricing has moved in favor of the parties doing deals. Premiums have compressed to roughly 2.5 to 3 percent of the policy limit in 2026, down from about 5 percent in early 2022, as carriers added capacity and deal volume cooled. Retentions, the insured equivalent of a deductible, have fallen to about 0.5 to 1 percent of enterprise value, meaningfully lower than what the market treated as standard a few years ago.

The product has also moved down-market. Representations and warranties insurance was once reserved for large, private-equity-backed transactions. It now appears routinely on deals with $5 million or more of EBITDA, and brokers report placements on transactions as small as $5 to $10 million in enterprise value. A typical program carries a minimum premium near $100,000 plus an underwriting fee of roughly $25,000 to $50,000 that covers the insurer's review of the buyer's diligence, which together set a practical floor on when the economics make sense.

That underwriting review is worth understanding, because it shapes the timeline. Before a carrier will bind coverage, it reads the buyer's due diligence reports, the draft purchase agreement, and the disclosure schedules, then holds a call to probe the gaps. A thin diligence file slows the process or narrows the coverage. For a lower-middle-market owner, the takeaway is that a tool that used to sit out of reach is now a realistic part of deal structure, and its cost has come down while the terms have grown more accommodating.

Section divider

How It Changes a Seller's Proceeds and Risk

The clearest benefit to a seller is the timing and certainty of proceeds. When insurance backstops the representations, the buyer needs far less security from the seller, so the escrow shrinks or disappears. Instead of leaving 10 percent of the price on the table for 18 months, a seller might leave a fraction of that, sometimes only enough to cover the policy retention. More of the purchase price arrives at closing, and less of it depends on how the business performs or what surfaces after the sale.

The structure also caps the tail. In a traditional deal, a seller who signed broad representations could face claims for months or years, with the escrow as a first stop and personal exposure behind it. Under an insured structure, the seller's residual liability is often limited to its share of the retention, with the insurer absorbing losses above that line. That cleaner break matters most to owners who are retiring, reinvesting the proceeds, or simply unwilling to carry a contingent liability into the next chapter.

There is a competitive angle as well. A buyer who brings representations and warranties insurance to the table can offer a seller-friendly risk profile without taking on much more of its own exposure. In a market where buyers have grown selective, an insured structure can make one bid more attractive than another at the same headline price.

The question is no longer only how much a buyer will pay, but how much of that price the seller actually keeps, and how long any of it stays at risk.

Where the Coverage Stops

Insurance does not cover everything, and the gaps are where sellers get surprised. The most important exclusion is for known issues. If diligence uncovers a specific problem, a tax position the parties know is shaky or a contract dispute already in motion, the policy will carve it out, and the parties have to handle that risk separately, often through a targeted indemnity or a price adjustment. The insurer prices and covers unknown breaches, not problems already sitting on the table.

That makes disclosure discipline more important, not less. A seller still has to stand behind accurate representations and a complete disclosure schedule, because a material misstatement can jeopardize coverage and revive direct claims against the seller. Buyers, for their part, now insist on what the market calls back-to-back alignment: the indemnification terms in the purchase agreement and the triggers in the policy must line up, so no gap opens between what the contract promises and what the insurer will actually pay.

The claims data reinforces where attention belongs. Financial statement issues and material contract problems remain the most frequent and most costly sources of claims, and insurers report that the size of the average paid claim has been rising. Neither party benefits from a thin diligence file or a rushed disclosure schedule.

Key Considerations Before Agreeing to an Insured Deal

The Bottom Line

Representations and warranties insurance has matured from a large-deal specialty into a practical option for lower-middle-market sellers, and the 2026 market offers lower premiums, smaller retentions, and access on deals that would not have qualified a few years ago. For an owner, the appeal is concrete: more cash at closing, a smaller escrow, and a cleaner exit with limited tail risk. The tradeoffs are just as concrete, because the policy excludes known problems, depends on disciplined disclosure, and adds cost that only makes sense above a certain deal size. Owners planning a sale should raise the option with their advisors early, model it against a traditional escrow structure, and decide before going to market whether an insured deal fits the outcome they want.

Disclaimer: This article is for informational purposes only and does not constitute financial, investment, tax, or legal advice. KAS Advisors recommends consulting with qualified professionals before making business or financial decisions. Past performance and market trends discussed herein are not indicative of future results.